Moderna Claims COVID-19 Vaccine 94.5% Effective, an Industrial Info Market Brief
Moderna Claims COVID-19 Vaccine 94.5% Effective, an Industrial Info Market Brief
Attachment: moderna
Recent reports from Moderna claim the company's experimental vaccine is 94.5% effective in preventing COVID-19, similar to results reported by Pfizer and BioNTech for their own vaccine. The positive finding was based on 95 cases of COVID-19, 90 of which were in study volunteers who received a placebo, versus five that occurred among those given Moderna's vaccine.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects